Dr. Norman Fishman, MD

Endocrinology physician, Chesterfield, MO

Diabetes & Endocrinology Specialists, Inc.

Dr. Fishman is an endocrinology physician at Diabetes & Endocrinology Specialists.

222 S. Woods Mill Rd., #410N, Chesterfield, MO 63017

Facts on this page last checked October 2026. How we check doctors

About Dr. Fishman

Dr. Fishman received his M.D. from Columbia University in 1974. He completed residency in internal medicine at Barnes Hospital in 1977. His fellowship training was at Barnes-Jewish Hospital.

He has been board certified in internal medicine since 1975 and in endocrinology and metabolism since 1979. At St. Luke's Hospital in Chesterfield, MO, he co-directs the training program for endocrinology and diabetes. He also works as a Clinical Research Investigator alongside his full-time practice.

Membership and fees

Fees are not published. Ask the practice.

Education and credentials

Degree
MD
Medical school
Columbia University (1974)
Residency
Internal medicine, Barnes Hospital (1977)
Fellowship
Barnes-Jewish Hospital
Board certification
Internal medicine (since 1975), endocrinology and metabolism (since 1979)
NPI
1528086659

Location

222 S. Woods Mill Rd., #410N, Chesterfield, MO 63017
Diabetes & Endocrinology Specialists, Inc. practice page
Directions

Recognition and research

Awards

Voted among the Best Doctors in St. Louis from 2013 to 2020, together with the practice's other two doctors.

Teaching and research roles

Clinical Research Investigator while in full-time medical practice.

Publications

"Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules", Journal of the American Society of Cytopathology, 2020.
"Clinical impact of testing for mutations and microRNAs in thyroid nodules", Diagnostic Cytopathology, 2019.
"Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial", The Lancet Diabetes & Endocrinology, 2017.
"Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study", Diabetes Care, 2018.
"Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial", The Lancet, 2018.

Patient reviews

Be the first to review Dr. Fishman.
Write a review

Questions patients ask

Is Dr. Fishman board certified?

Dr. Fishman has been board certified in internal medicine since 1975. He has been board certified in endocrinology and metabolism since 1979.

Where did Dr. Fishman train?

Dr. Fishman received his M.D. from Columbia University in 1974. He completed residency in internal medicine at Barnes Hospital in 1977.

Where is Dr. Fishman's office?

Dr. Fishman is affiliated with St. Luke's Hospital and co-directs a training program there in Chesterfield, MO.

Are you Dr. Fishman? Claim this profile for free. Report a correction.

Ready to contact Diabetes & Endocrinology Specialists, Inc.?